Characterization of two HDL subfractions and LpA-I, LpA-I:A-II distribution profiles and clinical characteristics of hyperalphalipoproteinemic subjects without cholesterol ester transfer protein deficiency

Atherosclerosis

Volumn 138, Issue 2, 1998, Pages 351-360

  Sich, Didier ^a   Saïdi, Youssef ^a   Giral, Philippe ^b   Lagrost, Laurent ^c   Dallongeville, Jean ^d   Federspiel, Marie Christine ^a   Cherfils, Corinne ^a   Raisonnier, Alain ^a   Turpin, Gérard ^b   Beucler, Isabel ^a  

^a P   (France)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^c INSERM   (France)

^d INSTITUT PASTEUR DE LILLE   (France)

Author keywords

A II; Cholesteryl ester transfer protein; HDL subfractions; Hyperalphalipoproteinemia; Lipoprotein A I

Indexed keywords

CHOLESTEROL ESTER TRANSFER PROTEIN; HIGH DENSITY LIPOPROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPOPROTEIN A; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGED; ARTERY INTIMA PROLIFERATION; ARTICLE; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CLINICAL ARTICLE; CONTROLLED STUDY; ECHOGRAPHY; FEMALE; HUMAN; HYPERCHOLESTEROLEMIA; HYPERLIPOPROTEINEMIA; LIPOPROTEIN BLOOD LEVEL; MALE; PRIORITY JOURNAL; PROTEIN DEFECT;

ADULT; APOLIPOPROTEIN A-I; APOLIPOPROTEIN A-II; CARRIER PROTEINS; CHOLESTEROL ESTER TRANSFER PROTEINS; FEMALE; GLYCOPROTEINS; HUMANS; HYPERLIPOPROTEINEMIAS; LIPOPROTEINS, HDL; MALE; MIDDLE AGED;

EID: 0032104068     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(98)00030-6     Document Type: Article

References (57)

1. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990's. Nature. 362:1993;801-809.
2. Wallace R.B., Anderson R.A. Blood lipids, lipid-related measures and the risk of atherosclerotic cardiovascular diseases. Epidemiol Rev. 9:1987;95-119.
3. Gordon D.J., Rifkind B.M. High-density lipoprotein: the clinical implication of recent studies. New Engl J Med. 321:1989;1311-1316.
4. Miller G.J., Miller N.E. Plasma HDL concentration and development of ischemic heart disease. Lancet. 1:1975;16-19.
5. Barter P. High-density lipoproteins and reverse cholesterol transport. Curr Opin Lipidol. 4:1993;210-217.
6. Fielding C.J., Fielding P.E. Molecular physiology of reverse cholesterol transport. J Lipid Res. 36:1995;211-228.
7. De Lalla O.F., Gofman J.W. Ultracentrifugal analysis of serum lipoproteins. Methods Biochem Anal. 1:1954;459-478.
8. Cheung M.C., Albers J.J. Characterization of lipoprotein particles isolated by immunoaffinity. J Biol Chem. 259:1984;12201-12209.
9. Miller N.E. Associations of high-density lipoprotein subclasses and apolipoproteins with ischemic heart disease and coronary atherosclerosis. Heart. 113:1984;589-597.
10. 3 and other major lipoprotein classes in survivors of myocardial infarction. Artery. 5:1979;495-508.
11. Puchois P., Kandoussi A., Fievet P.et al. Apolipoprotein A-I-containing lipoproteins in coronary artery disease. Atherosclerosis. 68:1987;35-40.
12. Rader D.J., Schaefer J.R., Lohse P.et al. Increased production of apolipoprotein A-I associated with elevated plasma levels of high density lipoproteins, apolipoprotein A-I and lipoprotein A-I in a patient with familial hyperalphalipoproteinemia. Metabolism. 42:1993;1429-1434.
13. Kuusi T., Ehnholm C., Viikari J.et al. Postheparin plasma lipoprotein and hepatic lipase are determinants of hypo- and hyperalphalipoproteinemia. J Lipid Res. 30:1989;1117-1126.
14. Brown M.L., Inazu A., Hesler C.B.et al. Molecular basis of lipid transfer protein deficiency in a family with increased high-density lipoproteins. Nature. 342:1989;448-451.
15. Sakai N., Yamashita S., Hirano K.H.et al. Frequency of exon 15 missense mutation (442D:G) in cholesteryl ester transfer protein gene in hyperalphalipoproteinemic Japanese subjects. Atherosclerosis. 114:1995;139-145.
16. Yamashita S., Hui D.Y., Wetterau J.R.et al. Characterization of plasma lipoproteins in patients heterozygous for human plasma cholesteryl ester transfer protein (CETP) deficiency: plasma CETP regulates high-density lipoprotein concentration and composition. Metabolism. 40(7):1991;756-763.
17. Takahashi K., Jiang X.-C., Sakai N.et al. A missense mutation in the cholesteryl ester transfer protein gene with possible dominant effects on plasma high density lipoproteins. J Clin Invest. 92:1993;2060-2064.
18. Inazu A., Brown M.L., Hesler C.B.et al. Increased high-density lipoprotein levels caused by a common cholesteryl-ester transfer protein gene mutation. New Engl J Med. 323:1990;1234-1238.
19. Hirano K., Yamashita S., Nakajima N.et al. Genetic cholesteryl ester transfer protein deficiency is extremely frequent in the Omagari area of Japan: marked hyperalphalipoproteinemia caused by CETP gene mutation is not associated with longevity. Arterioscler Thromb Vasc Biol. 17:1997;1053-1059.
20. Zhong S., Sharp D.S., Grove J.S.et al. Increased coronary heart disease in Japanese-American men with mutation in the cholesteryl ester transfer protein gene despite increased HDL levels. J Clin Invest. 97:1996;2917-2923.
21. Schaefer E.J., Lamon-Fava S., Ordovas J.M.et al. Factors associated to low and elevated plasma high density lipoprotein cholesterol and apolipoprotein A-I levels in the Framingham offspring study. J Lipid Res. 35:1994;871-882.
22. Bruckert E., Giral P., Salloum J.et al. Carotid stenosis is a powerful predictor of a positive exercise electrocardiogram in a large hyperlipidemic population. Atherosclerosis. 92:1992;105-114.
23. Friedewald W.T., Levy R.I., Frederickson D.S. Estimation of the concentration of low density lipoprotein cholesterol in plasma without preparative ultracentrifugation. Clin Chem. 18:1972;499-503.
24. Parra H.J., Mezdour H., Ghalim N., Bard J.M., Fruchart J.C. Differential electroimmunoassay of human LpA-I lipoprotein particles on ready-to-use plates. Clin Chem. 36:1990;1431-1435.
25. Chapman M.J., Goldstein S., Lagrange D., Laplaud P.M. A density gradient ultracentrifugal procedure for the isolation of the major lipoprotein classes from human serum. J Lipid Res. 22:1981;339-358.
26. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the folin phenol reagent. J Biol Chem. 193:1951;265-273.
27. Bouthillier D., Sing C.F., Davignon J. Apolipoprotein E phenotyping with a single gel method: application to the study of informative matings. J Lipid Res. 24:1983;1060-1069.
28. Menzel H.J., Kladetzky R., Assmann G. One-step screening method for the polymorphism of apolipoprotein A-I, A-II and A-IV. J Lipid Res. 23:1982;915-922.
29. Lagrost L., Gandjini H., Athias A., Guyard-Dangremont V., Lallemant C., Gambert P. Influence of plasma cholesteryl ester transfer activity on the LDL and HDL distribution profiles in normolipidemic subjects. Arterioscler Thromb. 13:1993;815-825.
30. Albers J.J., Tollefson J.H., Chen C.-H., Steinmetz A. Isolation and characterization of human plasma lipid transfer proteins. Arteriosclerosis. 4:1984;49-58.
31. Mann C.J., Yen F.T., Grant A.M., Bihain B.E. Mechanism of plasma cholesteryl ester transfer in hypertriglyceridemia. J Clin Invest. 88:1991;2059-2066.
32. Guyard-Dangremont V., Lagrost L., Gambert P., Lallemant C. Competitive enzyme-linked immunosorbent assay of the human cholesteryl ester transfer protein (CETP). Clin Chim Acta. 231:1994;147-160.
33. Scanu AM, Kruski AW. The chemistry of serum lipoproteins. In: Masoro E editor. International Encyclopedia of Pharmacology and Therapeutics. New York: Plenum,1985:21-38.
34. Patsch J.R., Sailer S., Kostner G., Sandhofer F., Holasek A., Braunsteiner H. Separation of the main lipoprotein density classes from human plasma by rate-zonal ultracentrifugation. J Lipid Res. 15:1974;356-366.
35. Shepherd J., Packard C.J., Patsch J.R., Gotto A.M., Taunton C.D. Effects of nicotinic acid therapy on plasma high density lipoprotein subfraction distribution and composition and on apolipoprotein A metabolism. J Clin Invest. 63:1979;858-867.
36. Nichols A.V. Human serum lipoproteins and their interrelationships. Adv Biol Med Phys. 11:1967;109-158.
37. Schaefer E.J., Lamon-Fava S., Cohn S.D.et al. Effects of age, gender, and menopausal status on plasma low density lipoprotein cholesterol and apolipoprotein B levels in the Framingham Offspring Study. J Lipid Res. 35:1994;779-792.
38. Assmann G editor. In: Lipid Metabolism Disorders and Coronary Heart Disease. München, Germany: MMV Medizin, 1993:21-68.
39. Wofford J.L., Kahl F.R., Howard G.R., McKinney W.M., Tool J.F., Crouse III J.R. Relation of extent of extracranial carotid artery atherosclerosis as measured by B mode ultrasound to the extent of coronary atherosclerosis. Arterioscler Thromb. 11:1991;1786-1794.
40. Salonen J.T., Salonen R. Ultrasonographically assessed carotid morphology and the risk of coronary heart disease. Arterioscler Thromb. 11:1991;1245-1249.
41. Robinson D., Gordon A., Ferns A.et al. High density lipoprotein subfractions and coronary risk factors in normal men. Arterioscler. 7:1987;341-346.
42. Parra H.J., Arveiler D., Evans A.E.et al. A case-control study of lipoprotein particles in two populations at contrasting risk for coronary heart disease: the ECTIM study. Arterioscler Thromb. 12:1992;701-707.
43. Cheung M.C., Segrest J.P., Albers J.J.et al. Characterization of high density lipoprotein subspecies: structural studies by single vertical spin ultracentrifugation and immunoaffinity chromatography. J Lipid Res. 28:1987;913-929.
44. Cheung M.C., Brown G.B., Wolf A.C., Albers J.J. Altered particle size distribution of apolipoprotein A-I-containing lipoproteins in subjects with coronary artery disease. J Lipid Res. 32:1991;383-394.
45. Duverger N., Rader D., Duchateau P., Fruchart J.C., Castro G., Brewer B.H. Jr. Biochemical characterization of the three major subclasses of lipoprotein A-I preparatively isolated from human plasma. Biochemistry. 32:1993;12372-12379.
46. Decossin C., Castro G., Derudas B., Bertrand M., Fruchart J.C., Fiévet C. Subclasses of LpA-I in coronary artery disease: distribution and cholesterol efflux ability. Eur J Clin Invest. 27:1997;299-307.
47. Rader D.J., Castro G., Zech L.A., Fruchart J.C., Brewer H.B. Jr. In vivo metabolism of apolipoprotein A-I on high density lipoprotein particles LpA-I and LpA-I, A-II. J Lipid Res. 32:1991;1849-1859.
48. Marzetta C.A., Meyers T.J., Albers J.J. Lipid transfer protein-mediated distribution of HDL-derived cholesteryl esters among plasma apoB-containing lipoprotein subpopulations. Arterioscler Thromb. 13:1993;834-841.
49. Murakami T., Michelagnoli S., Longhi R.et al. Triglycerides are major determinants of cholesterol esterification/transfer and HDL remodeling in human plasma. Arterioscler Thromb Vasc Biol. 15:1995;1819-1828.
50. Bagdade J.D., Ritter M.C., Subbaiah P.V. Accelerated cholesteryl ester transfer in plasma of patients with hypercholesterolemia. J Clin Invest. 87:1991;1259-1265.
51. McPherson R., Mann C.J., Tall A.R.et al. Plasma concentrations of cholesteryl ester transfer protein in hyperlipoproteinemia: relation to cholesteryl ester transfer protein activity and other lipoprotein variables. Arterioscler Thromb. 11:1991;797-804.
52. Jiang X.C., Agellon L.B., Walsh A., Breslow J.L., Tall A. Dietary cholesterol increases transcription of the human cholesteryl ester transfer protein gene in transgenic mice. J Clin Invest. 90:1992;1290-1295.
53. Hirano K., Yamashita S., Kuga Y.et al. Atherosclerotic disease in marked hyperalphalipoproteinemia. Combined reduction of cholesteryl ester transfer protein and hepatic triglyceride lipase. Arterioscler Thromb Vasc Biol. 15:1995;1849-1856.
54. Hegele R.A., Little J.A., Vezina C.et al. Hepatic lipase deficiency: clinical, biochemical and molecular genetic characteristics. Arterioscler Thromb. 13:1993;720-728.
55. Funke H., Von Eckardstein A., Pritchard P.H., Karas M., Albers J.J., Assmann G. A frameshift mutation in the human apolipoprotein A-I gene causes high density lipoprotein deficiency, partial lecithin:cholesterol acyl transferase deficiency, and corneal opacities. A disorder which is distinct from fish-eye disease. J Clin Invest. 87:1991;371-376.
56. Lackner K.J., Dieplinger H., Nowicka G., Schmitz G. High density lipoprotein deficiency with xanthomas: a defect in reverse cholesterol transport caused by a point mutation in the apolipoprotein A-I gene. J Clin Invest. 92:1993;2262-2273.
57. Pagani F., Sidoli A., Giudici G.A., Barenghi C., Vergani C., Baralle F.E. Human apolipoprotein A-I gene promoter polymorphism: association with hyperalphalipoproteinemia. J Lipid Res. 31:1990;1371-1377.